Experimental model of chronic renal allograft rejection in rats and therapeutic efficacy of a new selective thromboxane A2 (TXA2) synthetase inhibitor (CV-4151).
Tanabe
K
K
Department of Urology and Surgery, Kidney Center, Tokyo, Japan.
Toma
H
H
Sagara
R
R
Takahashi
K
K
Teraoka
S
S
Ota
K
K
D000818:Animals; D001794:Blood Pressure; D002908:Chronic Disease; D004195:Disease Models, Animal; D005229:Fatty Acids, Monounsaturated / Q000627:therapeutic use*; D006084:Graft Rejection; D007668:Kidney / Q000503:physiopathology; D016030:Kidney Transplantation; D011725:Pyridines / Q000627:therapeutic use*; D051381:Rats; D011916:Rats, Inbred F344; D011917:Rats, Inbred Lew; D012016:Reference Values; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D005229:Fatty Acids, Monounsaturated; D011725:Pyridines; D013930:Thromboxane-A Synthase; C045446:isbogrel